Related Experiment Videos
Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value
D C Mangham1, D C Rowlands, K M Newbold
1Department of Pathology, University of Birmingham.
Journal of Clinical Pathology
|May 1, 1994
Abstract:
It has been proposed that immunostaining with PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA), is of prognostic value in gastric carcinoma. Gastric carcinomas from a series of 90 patients in whom survival data were known have been studied. There was no relation between the degree of PC10 immunostaining assessed semiquantitatively and survival.